<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: EXEL News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=exel</link><description>Latest Financial News for Exelixis, Inc.</description><language>en-us</language><lastBuildDate>Wed, 23 Dec 2009 22:08:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>EXELIXIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091223/exel8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3036282955</guid><pubDate>Wed, 23 Dec 2009 22:08:00 Etc/GMT</pubDate></item><item><title>Exelixis, Inc.: Warming Up or Cooling Off? (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=130jk7kob/*http%3A//www.fool.com/investing/general/2009/12/22/exelixis-inc-warming-up-or-cooling-off.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1211827509</guid><pubDate>Tue, 22 Dec 2009 19:18:52 Etc/GMT</pubDate></item><item><title>Goodman named to Texas drug company board (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kgnro4c/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/12/14/daily29.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/164267569</guid><pubDate>Tue, 15 Dec 2009 23:05:23 Etc/GMT</pubDate></item><item><title>EXELIXIS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/exel8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2663076646</guid><pubDate>Fri, 11 Dec 2009 22:20:45 Etc/GMT</pubDate></item><item><title>5 Stocks Bouncing Back (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12gou9ecd/*http%3A//www.fool.com/investing/general/2009/12/11/5-stocks-bouncing-back.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1823260573</guid><pubDate>Fri, 11 Dec 2009 18:44:00 Etc/GMT</pubDate></item><item><title>Exelixis Announces January 12 Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091209/20091209005337.html?.v=1</link><description>SOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. announced today that George A. Scangos, PhD, the company’s president and chief executive officer, will present at the 28th Annual J.P. Morgan Healthcare Conference at 11:00 a.m.</description><guid isPermaLink="false">yahoo_finance/1947584133</guid><pubDate>Wed, 9 Dec 2009 11:30:00 Etc/GMT</pubDate></item><item><title>EXELIXIS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091207/exel8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3774513497</guid><pubDate>Mon, 7 Dec 2009 22:23:32 Etc/GMT</pubDate></item><item><title>Biotech Bargains for Your Portfolio (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=131o4jup1/*http%3A//www.fool.com/investing/high-growth/2009/11/27/biotech-bargains-for-your-portfolio.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2757966048</guid><pubDate>Fri, 27 Nov 2009 15:58:57 Etc/GMT</pubDate></item><item><title>4-Star Stocks Poised to Pop: Cytori Therapeutics (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=139set9op/*http%3A//www.fool.com/investing/general/2009/11/27/4-star-stocks-poised-to-pop-cytori-therapeutics.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3114632327</guid><pubDate>Fri, 27 Nov 2009 14:49:13 Etc/GMT</pubDate></item><item><title>Exelixis Announces December 1 Webcast of Presentation at Piper Jaffray&apos;s 21st Annual Healthcare Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091125/20091125005657.html?.v=1</link><description>SOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. announced today that Charles Butler, the company’s vice president, investor relations and corporate communications, will present at Piper Jaffray’s 21st Annual Healthcare Conference at 1:30 p.m.</description><guid isPermaLink="false">yahoo_finance/2963117252</guid><pubDate>Wed, 25 Nov 2009 19:15:00 Etc/GMT</pubDate></item><item><title>Exelixis Announces Webcast of Its Fifth Annual R&amp;D Day on December 2 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091124/20091124005290.html?.v=1</link><description>SOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. announced today that it will hold its Fifth Annual R&amp;D Day on Wednesday, December 2, 2009 from 10:00 a.m. EST / 7:00 a.m. PST to 2:00 p.m.</description><guid isPermaLink="false">yahoo_finance/4078024769</guid><pubDate>Tue, 24 Nov 2009 13:30:00 Etc/GMT</pubDate></item><item><title>Icahn Makes Big Moves in Healthcare Stocks (Indie Research)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091123/2576_id.html?.v=1</link><description>Legendary investor Carl Icahn is known for making headlines with big moves in the market.</description><guid isPermaLink="false">yahoo_finance/935025747</guid><pubDate>Mon, 23 Nov 2009 14:13:00 Etc/GMT</pubDate></item><item><title>Four Healthcare Stocks On Fire (at Investopedia)</title><link>http://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=13oo1uii5/*http%3A//stocks.investopedia.com/stock-analysis/2009/Four-Healthcare-Stocks-On-Fire-NVS-EXEL-SNY-BMY-ISRG-WCG1118.aspx?partner=YahooSA</link><description></description><guid isPermaLink="false">yahoo_finance/2351179426</guid><pubDate>Wed, 18 Nov 2009 22:13:31 Etc/GMT</pubDate></item><item><title>9 Things You Should Do Instead of Buying Stocks (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13dtvp42a/*http%3A//www.fool.com/investing/high-growth/2009/11/18/9-things-you-should-do-instead-of-buying-stocks.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2582108669</guid><pubDate>Wed, 18 Nov 2009 19:17:42 Etc/GMT</pubDate></item><item><title>Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor Xl147 (SAR245408) in Combination with Erlotinib at the AACR-NCI-EORTC Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091118/20091118005423.html?.v=1</link><description>BOSTON----Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.</description><guid isPermaLink="false">yahoo_finance/804602127</guid><pubDate>Wed, 18 Nov 2009 17:30:00 Etc/GMT</pubDate></item><item><title>Exelixis downgraded by Merriman (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=EXEL</link><description></description><guid isPermaLink="false">yahoo_finance/3623637453</guid><pubDate>Wed, 18 Nov 2009 06:08:13 Etc/GMT</pubDate></item><item><title>Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor XL147 (SAR245408) in Combination with Paclitaxel and Carboplatin at the AACR-NCI-EORTC Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091117/20091117006104.html?.v=1</link><description>BOSTON----Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 in combination with paclitaxel and carboplatin in patients with advanced solid tumors.</description><guid isPermaLink="false">yahoo_finance/731031728</guid><pubDate>Tue, 17 Nov 2009 17:30:00 Etc/GMT</pubDate></item><item><title>Cramer&apos;s Stop Trading! Why Is Boeing Flying? (11/16/09) (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12uq2b7th/*http%3A//seekingalpha.com/article/173690-cramer-s-stop-trading-why-is-boeing-flying-11-16-09?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2262267696</guid><pubDate>Tue, 17 Nov 2009 12:04:44 Etc/GMT</pubDate></item><item><title>Cramer: Retail Investors Returning to Market? (at CNBC)</title><link>http://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11hpna28l/*http%3A//www.cnbc.com/id/33967825/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3834728335</guid><pubDate>Mon, 16 Nov 2009 20:34:36 Etc/GMT</pubDate></item><item><title>Exelixis Announces November 18 Webcast of Presentation at Lazard&apos;s 6th Annual Healthcare Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091113/20091113005143.html?.v=1</link><description>SOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. announced today that Frank Karbe, the company’s executive vice president and chief financial officer, will present at Lazard’s 6th Annual Healthcare Conference at 11:00 a.m.</description><guid isPermaLink="false">yahoo_finance/2403514226</guid><pubDate>Fri, 13 Nov 2009 13:30:00 Etc/GMT</pubDate></item></channel></rss><!-- c8.finance.sp2.yahoo.com compressed/chunked Sat Dec 26 07:17:00 PST 2009 -->
